ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
After-hours: Aug 15, 2025, 07:33 PM EDT

ESSA Pharma Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-8.53M -6.36M -7.23M -8.99M -5.96M -5.48M -7.3M -7.06M -6.74M -6.32M -8.83M -10.85M -9.1M -8.56M -8.75M -12.97M -6.53M
Depreciation & Amortization
23.41K -61.18K 22.66K 15.5K 23.01K 27.15K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 28.8K 25.5K 27.58K 27.58K
Stock-Based Compensation
2.7M 2M 2.6M 1.13M 803.42K 845.69K 1.16M 1.44M 1.56M 1.93M 1.59M 1.86M 2.5M 2.82M 2.78M 2.66M 1.2M
Other Working Capital
-408.03K 269.46K -645.22K 981.14K -991.15K 227.42K 1.65M -348.79K 940.18K -2.96M 776.12K 774.63K 938.69K -1.97M 122.74K 562.7K 564.71K
Other Non-Cash Items
-264.01K 757.52K -520.58K 1.21M -408.33K 82.84K 1.46M -1.04M -778.67K -541.31K -205.58K -172.89K -35.08K 1.93K -18.6K -14.8K -3.83K
Deferred Income Tax
n/a n/a n/a n/a -204.07K -188.29K -204.21K n/a n/a n/a n/a n/a 124.08K -603.65K -565.76K 1.14M -75.18K
Change in Working Capital
-399.4K 290.07K -613.63K 946.18K -1.04M 225.53K 1.52M -342.94K 931.75K -2.95M 767.45K 748.55K 658.74K -1.07M 9.65K 1.58M 1.43M
Operating Cash Flow
-6.47M -3.37M -5.75M -6.89M -6.79M -4.49M -3.32M -6.97M -4.99M -7.86M -6.64M -8.39M -5.82M -7.38M -6.52M -7.57M -3.94M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-12.03M -11.47M -5.48M 38.59M -60.99M -106.9M -80M -87.83M -90.48M -98.05M -93.14M -89.8M -15.01M 1.85M -2.01M -55.83M n/a
Sales Maturities Of Investments
8.1M 32.49M 5.5M 24.28M 69.22M 106.63M 77.52M 88.54M 88.98M 94.38M 81.39M 63.18M 4.01M -712.13K 2M 20.3M n/a
Other Investing Acitivies
n/a n/a n/a 62.51M 8.23K -264.65 -2.47K -617.82K 617.82K 705.02K -12.08K -26.63M -11M n/a -11.29K -35M n/a
Investing Cash Flow
-3.93M 21.02M 23.49K 62.86M 8.23M -264.65K -2.47M 86.27K -876.34K -2.97M -11.75M -26.63M -11M 1.13M -11.29K -35M n/a
Debt Repayment
n/a n/a n/a n/a n/a -32.07K -35.52K -34.64K -34.64K -34.64K -34.64K -32.37K -32.37K -30.64K -9.06K -30.29K -30.29K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 59.67K 25.58K -4.21K 196.66K 18.42K n/a n/a 50.29K 5.7K 39.57K 215.51K 131.68K 43.97K 198.24K 141.67M 181.22K
Financial Cash Flow
n/a 59.67K 25.58K 647.82K 196.66K -13.65K -35.52K -34.64K 15.65K -34.64K 4.93K 183.13K 99.31K 13.32K 189.18K 141.64M 150.93K
Net Cash Flow
-10.4M 17.72M -5.7M 56.34M 1.64M -4.77M -5.83M -6.92M -5.86M -10.79M -18.37M -34.82M -16.77M -7.37M -6.37M 99.08M -3.84M
Free Cash Flow
-6.47M -3.37M -5.75M -6.89M -6.79M -4.49M -3.32M -6.97M -4.99M -7.86M -6.64M -8.39M -5.82M -7.38M -6.52M -7.57M -3.94M